For patients with systemic lupus erythematosus (SLE) and pericarditis, recurrence of pericarditis occurs in more than 20% of patients and associated factors include younger age, prednisone treatment, ...

“We are trying to maintain patient programs, but we need funding to do it and that is why the walk is so important," said ...

Merck’s lupus drug enpatoran has failed to meet the primary endpoint in a subgroup of patients, but the drug's development is ...

Living with lupus can be overwhelming, says columnist Candace Semien, but it's important to hold tight and fight for yourself ...

The TYK2 inhibitor deucravacitinib (Sotyktu) showed clinical potential in two diseases other than psoriasis, according to ...

Three months after Bristol Myers Squibb revealed the success of two phase 3 trials of its oral targeted therapy Sotyktu in ...

Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of ...

Exagen (NASDAQ:XGN – Get Free Report) is anticipated to issue its quarterly earnings data before the market opens on Tuesday, March 11th. Analysts expect the company to announce earnings of ($0.27) ...

Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) have earned a consensus rating of “Buy” from the six analysts ...

CB-010 ANTLER 2L LBCL and CB-011 CaMMouflage r/r MM Phase 1 clinical data expected in H1 2025 ---- Advancing four clinical programs for ...

系统性红斑狼疮（SLE）可导致多系统、多器官损害，临床表现复杂不一，但是SLE合并血栓性血小板减少性紫癜（TTP）较为罕见，现报告一例以TTP为首发症状的SLE，具体信息如下。病例介绍患者为17岁女性，以“乏力、浮肿20天，肉眼血尿7天”为主诉入院。

Everest Medicines' stock (1952.HK) surged today, opening higher and maintaining strong momentum throughout the trading day. By market close, the stock had risen 20.12% to HK$60.6, bringing the company ...